Literature DB >> 2095929

Inter-laboratory comparison of DNA flow cytometric results from paraffin-embedded breast carcinomas.

O P Kallioniemi1, H Joensuu, P Klemi, T Koivula.   

Abstract

Consecutive sections from 33 paraffin-embedded human breast carcinomas without intratumor heterogeneity were sent for flow cytometric (FCM) DNA analysis in two experienced laboratories. FCM instruments, run conditions, and tumor disaggregation procedures were different in the two laboratories. In four cases (12%) the laboratories reported a different DNA ploidy and DNA index (DI). These variations were due to analytical reasons, differences in the detection rates of near-diploid and tetraploid DIs, not due to interpretation of data or the criteria used for aneuploidy. There was a significant correlation between S-phase fractions (SPF) obtained in the two laboratories (r = 0.90, p less than 0.0001) if only cases with concordant DI were included. Discordant DI usually led to very different SPF values.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2095929     DOI: 10.1007/bf01812686

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  8 in total

1.  DNA flow cytometry in the prognosis of node-negative breast cancer.

Authors: 
Journal:  N Engl J Med       Date:  1989-08-17       Impact factor: 91.245

2.  Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry.

Authors:  G M Clark; L G Dressler; M A Owens; G Pounds; T Oldaker; W L McGuire
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

3.  Interinstitutional variability in DNA flow cytometric analysis of tumors. The National Cancer Institute's Flow Cytometry Network Experience.

Authors:  J S Coon; A D Deitch; R W de Vere White; L G Koss; M R Melamed; J E Reeder; R S Weinstein; R P Wersto; L L Wheeless
Journal:  Cancer       Date:  1988-01-01       Impact factor: 6.860

4.  Different opinions on classification of DNA histograms produced from paraffin-embedded tissue.

Authors:  H Joensuu; O P Kallioniemi
Journal:  Cytometry       Date:  1989-11

5.  Reproducibility of flow cytometric assessment of follicular tumours of the thyroid.

Authors:  T P van Thiel; J C van der Linden; J P Baak; M M van de Sandt; C van Galen; P D Bezemer
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

6.  Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction. A proposed classification of DNA histograms in breast cancer.

Authors:  O P Kallioniemi; G Blanco; M Alavaikko; T Hietanen; J Mattila; K Lauslahti; M Lehtinen; T Koivula
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

7.  Assessment of interlaboratory variability in analytical cytology. Results of the College of American Pathologists Flow Cytometry Study.

Authors:  H A Homburger; R McCarthy; S Deodhar
Journal:  Arch Pathol Lab Med       Date:  1989-06       Impact factor: 5.534

8.  The prognostic significance of nuclear DNA content in invasive breast cancer--a study with long-term follow-up.

Authors:  S Toikkanen; H Joensuu; P Klemi
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

  8 in total
  2 in total

Review 1.  DNA Cytometry Consensus Conference. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast.

Authors:  D W Hedley; G M Clark; C J Cornelisse; D Killander; T Kute; D Merkel
Journal:  Breast Cancer Res Treat       Date:  1993-10       Impact factor: 4.872

2.  S-phase fraction identifies high-risk subgroups among DNA-diploid breast cancers.

Authors:  H Romero; J Schneider; J Burgos; J Bilbao; F J Rodriguez-Escudero
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.